Physical pressure can stop cancer cells from growing large enough to divide, revealing why squeezed tumors may stall.

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with ...

One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in ...

Onc.AI, a digital health company developing computational biomarkers and decision-support products in oncology using Deep Learning imaging AI, today announced positive external validation results for ...

The Lafayette Parish Sheriff's Office has taken issue with a report of an arrest by ICE agents in an online news source.

Durvalumab monotherapy did not meet the prespecified statistical threshold for DFS versus active monitoring, despite a 6-point absolute 3-year DFS difference (78% vs 72%). RAMPART enrolled ...

PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing ...

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Long regarded as cells involved primarily in allergic responses and antiparasitic defense, eosinophils are now drawing ...

Tumor immune surveillance plays a pivotal role in preventing tumor formation, progression, and metastatic spread. However, cancer cells exploit several ...

Eight people who had surgery for pancreatic cancer and then received a vaccine built from their own tumor DNA have now gone ...

Researchers at VIB, Ghent University, and VUB have uncovered how two proteins essential for immune cell development work together at the molecular level. The findings provide important insights into a ...